Diabetic macular edema: Towards therapy aimed at the underlying pathogenic mechanisms

Israel Medical Association Journal

Volumn 8, Issue 2, 2006, Pages 127-128

  Averbukh, Edward ^a   Banin, Eyal ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Diabetic macular edema; Diabetic retinopathy; Triamcinolone acetate; Vascular endothelial growth factor

Indexed keywords

PEGAPTANIB; RUBOXISTAURIN; STEROID; TRIAMCINOLONE ACETATE; VASCULOTROPIN ANTIBODY;

BLINDNESS; CAPILLARY FLOW; CLINICAL TRIAL; DIABETES MELLITUS; DIABETIC MACULAR EDEMA; DIABETIC MICROANGIOPATHY; DIABETIC RETINOPATHY; DRUG EFFICACY; EDITORIAL; HUMAN; LASER COAGULATION; PATHOGENESIS; PATHOPHYSIOLOGY; QUALITY OF LIFE; RETINA CAPILLARY; STEROID THERAPY; TREATMENT PLANNING; VISUAL IMPAIRMENT; VITRECTOMY;

ANTI-INFLAMMATORY AGENTS; DIABETIC RETINOPATHY; FOVEA CENTRALIS; GLUCOCORTICOIDS; HUMANS; INJECTIONS; MACULAR EDEMA, CYSTOID; TRIAMCINOLONE ACETONIDE; VITREOUS BODY;

EID: 33244464783     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (9)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27(5):1047-53.
2. van Wijngaarden P, Coster DJ, Williams KA. Inhibitors of ocular neovascularization: promises and potential problems, JAMA 2005; 293(12):1509-13.
3. Chiasson JL, Brindisi MC, Rabasa-Lhoret R. The prevention of type 2 diabetes: what is the evidence? Minerva Endocrinol 2005; 30(3):179-91.
4. Fong DS, Aiello LP, Ferris FL 3rd, Klein R. Diabetic retinopathy. Diabetes Care 2004;27(10):2540-53.
5. Kotoula M, Koukoulis G, Zintzaras E, Karabatsas C, Chatzoulis D. Metabolic control of diabetes is associated with an improved response of diabetic retinopathy to panretinal photocoagulation, Diabetes Care 2005;28(10):2454-7.
6. The PKC-DRS Study Group Diabetes. The effect of ruboxistaurin on visual loss in patients with moderately severe to very severe nonproliferative diabetic retinopathy: initial results of the Protein Kinase C beta Inhibitor Diabetic Retinopathy Study (PKC-DRS) multicenter randomized clinical trial. Diabetes 2005;54(7):2188-97.
7. Cunningham ET Jr, Adamis AP, Altaweel M, et al. A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema. Ophthalmology 2005;112(10):1747-57.
8. Barak A, Regenbogen M, Goldstein M, Loewenstein A. Intravitreal triamcinolone injection for diffuse diabetic macular edema with foveal cystoid changes. IMAJ 2006;8:83-7.
9. Jonas JB, Kreissig I, Degenring R. Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases. Prog Retin Eye Res 2005;24(5):587-611.